You just read:

DelMar Pharmaceuticals Presents Data Supporting the Potential of VAL-083 as a New Treatment for Ovarian Cancer at the 11th Biennial Ovarian Cancer Research Symposium

News provided by

DelMar Pharmaceuticals, Inc.

13 Sep, 2016, 08:30 ET